Navigation Links
Akorn, Inc. Announces First Quarter 2012 Earnings Release and Conference Call Information
Date:4/17/2012

LAKE FOREST, Ill., April 17, 2012 /PRNewswire/ -- Akorn, Inc. (NASDAQ: AKRX) will host a conference call on Tuesday, May 8, 2012, to discuss first quarter 2012 results followed by a Q&A session.  The company will release earnings the same day before the market opens. Subject:Akorn, Inc. First Quarter 2012 Conference CallDate/Time:Tuesday, May 8, 2012, at 10:00 a.m. Eastern TimeDomestic Callers: 

(877) 723-9517International Callers: (719) 325-4747Confirmation Code:3062574URL For Webcast:http://www.videonewswire.com/event.asp?id=86591A live broadcast of Akorn's conference call will also be available online at www.akorn.com under the Investor Relations tab on May 8, 2012, beginning at 10:00 a.m. (Eastern Time).  The online replay will follow immediately and will be available for 30 days. 

About Akorn, Inc.Akorn, Inc. is a niche pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals.  Akorn has manufacturing facilities located in Decatur, Illinois and Somerset, New Jersey where the Company manufactures ophthalmic and injectable pharmaceuticals.  Additional information is available on the Company's website at www.akorn.com.

 

 


'/>"/>

SOURCE Akorn, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Akorn, Inc. Announces Third Quarter 2011 Earnings Release and Conference Call Information
2. Akorn, Inc. Announces Second Quarter 2011 Earnings Release and Conference Call Information
3. Akorn, Inc. Announces First Quarter 2011 Earnings Release and Conference Call Information
4. CORRECTED - Akorn, Inc. Announces Date Change for Third Quarter 2010 Earnings Release and Conference Call
5. Akorn, Inc. Announces Third Quarter 2010 Earnings Release and Conference Call Information
6. Tengion Announces IND Filing for Neo-Kidney Augment Expected During First Half of 2013
7. ConvaTec Healthcare Announces 2011 Year-end Earnings Call
8. The Galien Foundation Announces Prix Galien USA Awards Committee, Chaired by Dr. P. Roy Vagelos
9. Morphotek®, Inc. Announces Initiation of MORAb-004 Phase 2 Study in Metastatic Colorectal Cancer
10. Sangamo BioSciences Announces Presentation at the Future Leaders in the Biotech Industry Conference
11. Gamma Pharmaceuticals, Inc. Announces Distribution Agreement for New York Tri-state Area and Purchase Order for Gamma Energy GEL™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):